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Frailty is associated with adverse health outcomes in people with chronic kidney disease
(CKD). Evidence supporting targeted interventions is needed. This pilot randomised con-
trolled trial (RCT) aimed to inform the design of a definitive RCT evaluating the effectiveness
of a home-based exercise intervention for pre-frail and frail older adults with CKD.
Methods
Participants were recruited from nephrology outpatient clinics to this two-arm parallel group
mixed-methods pilot RCT. Inclusion criteria were:�65 years old; CKD G3b-5; and Clinical
Frailty Scale score�4. Participants categorised as pre-frail or frail using the Frailty Pheno-
type were randomised to a 12-week progressive multi-component home-based exercise
programme or usual care. Primary outcome measures included eligibility, recruitment,
adherence, outcome measure completion and participant attrition rate. Semi-structured
interviews were conducted with participants to explore trial and intervention acceptability.
Results
Six hundred and sixty-five patients had an eligibility assessment with 217 (33%; 95% CI
29, 36) eligible. Thirty-five (16%; 95% CI 12, 22) participants were recruited. Six were
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categorised as robust and withdrawn prior to randomisation. Fifteen participants were ran-
domised to exercise and 14 to usual care. Eleven (73%; 95% CI 45, 91) participants com-
pleted�2 exercise sessions/week. Retained participants completed all outcome measures
(n = 21; 100%; 95% CI 81, 100). Eight (28%; 95% CI 13, 47) participants were withdrawn.
Fifteen participated in interviews. Decision to participate/withdraw was influenced by per-
ceived risk of exercise worsening symptoms. Participant perceived benefits included
improved fitness, balance, strength, well-being, energy levels and confidence.
Conclusions
This pilot RCT demonstrates that progression to definitive RCT is possible provided recruit-
ment and retention challenges are addressed. It has also provided preliminary evidence that




Frailty is a state of increased vulnerability to a disproportionate decline in health status when
exposed to an insult, such as infection or trauma [1]. Frailty is highly prevalent in chronic con-
ditions, including chronic kidney disease (CKD) [2], within which underlying pathological
processes contribute to the development and advancement of the frailty syndrome [3]. Impor-
tantly, frailty and its precursor pre-frailty are associated with adverse health outcomes [4].
Within CKD populations, frailty is associated with worse health-related quality (HRQOL) [5],
falls [6], hospitalisation [7] and mortality [8]. Validated frailty screening and assessment tools
are available [9] and are increasingly used in clinical practice. However, evidence supporting
targeted interventions for people living with pre-frailty/frailty is still needed [10].
Physical inactivity and associated poor physical function are common in CKD and worsen
with disease progression [11,12]. Both are components of physical frailty [13,14] and are indi-
vidually associated with adverse health outcomes in CKD, including mortality [15]. Ramer
et al. [14] found that maintaining independence was an essential health outcome priority for
older people living with CKD. Maintenance of or increasing to a regular frequency of physical
activity can lead to improvement in physical frailty in older adults [16]. Greenwood et al.
[17,18] demonstrated that a renal rehabilitation programme can improve physical function
and is also associated with longer event-free survival in patients with CKD. Increasing physical
activity levels, therefore, may lead to improved physical function and, in turn, maintenance of
independence and improved survival rates in people living with frailty and CKD. However,
additional high quality trials are needed [19] that include people living with frailty, individuals
that are often poorly represented in interventional studies [20].
Home-based exercise programmes may be more effective in people living with frailty, as
they allow practice in a familiar functionally-relevant environment. Furthermore, the benefits
may be sustained in the longer term, as they are implemented without the need for direct
supervision, empowering patients to incorporate exercise within their daily lives. A recent sys-
tematic review and meta-analysis of exercise, including home-based exercise, in people with
non-dialysis chronic kidney disease demonstrated improvements in physical and walking
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capacity [21]. However, the authors acknowledged that the generalisability of findings is “lim-
ited by age” as the “approximate mean age of participates in the included trials ranged from 50
to 65 years” [21]. Studies in older frail non-CKD populations suggest that home-based exercise
interventions are feasible and may be associated with improved outcomes, in terms of frailty,
functional performance, nutritional status and falls incidence [22]. However, research is
needed to evaluate home-based exercise interventions tailored to the needs of older people liv-
ing with frailty and CKD [23].
The aim of the EX-FRAIL CKD Trial, a pilot randomised controlled trial (RCT), is to
inform the design of a definitive RCT that evaluates the effectiveness of a home-based exercise
intervention in pre-frail and frail older adults with CKD by: (1) evaluating the rate of eligibility,
recruitment, intervention adherence, outcome measure completion and attrition; (2) qualita-
tively exploring the acceptability of the randomisation procedure, outcome measures and, in
the intervention arm, of the progressive home-based exercise programme; and (3) estimate the
standard deviation of walking speed in pre-frail/frail people with CKD to inform the sample
size calculation for a definitive RCT. A pilot RCT was needed to address key uncertainties
prior to definitive evaluation of the intervention to maximise the success of a large-scale RCT.
Methods
This section will present an abridged version of the methods; a full description of the methods
has been published elsewhere [24]. Ethical approval was granted by the North West Greater
Manchester East Research Ethics Committee (reference 18/NW/0211) and the National Health
Service (NHS) Health Research Authority (project reference 244772).
Trial design
The EX-FRAIL CKD trial is a two-arm parallel group pilot RCT. Participants were allocated
in a ratio of 1:1 to 12-weeks of home-based exercise or usual care. Outcome assessments
were performed at baseline and 12-weeks’ post-randomisation. Final assessments were
delayed for some participants (specifically those who temporarily had the intervention
held due to an adverse event) to allow participants the opportunity to complete a total of
12-weeks of home-based exercise. Participants were invited to participate in a nested qualita-
tive study following 12-week assessments or following a participant’s decision to discontinue
the exercise programme.
Participants
Participants were recruited from Department of Renal Medicine outpatient clinics at the Lan-
cashire Teaching Hospitals NHS Foundation Trust (LTHTR). Inclusion criteria were: age�65
years old; CKD G3b-5 (not receiving dialysis or received a kidney transplant); and with a Clin-
ical Frailty Scale score�4 [25]. The Clinical Frailty Scale is a simple screening measure that
has been validated in people with advanced CKD at risk of frailty [9,25]. Exclusion criteria
were: unstable angina or recent (within the last 3 months) myocardial infarction; uncontrolled
arrhythmias; persistent uncontrolled hypertension (systolic blood pressure >180 mmHg or
diastolic blood pressure >110 mmHg); recent (within the last 3 months) stroke or transient
ischaemic attack; registered blind; unable to mobilise independently; receiving palliative care
for advanced terminal cancer; recently (within the last 12 months) enrolled in a structured
exercise programme (e.g. cardiac rehabilitation) prescribed by a health professional; antici-
pated to commence dialysis or receive a renal transplant within the next 3 months; insufficient
understanding of the English language to complete study questionnaires or follow advice
within the exercise programme guidebook; and clinical and/or research team consider
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participation in the exercise programme unsafe. Following written informed consent, partici-
pants underwent an objective frailty assessment, using the Frailty Phenotype (FP), to ensure
that only patients with pre-frailty or frailty were randomised.
Intervention
Table 1 describes the intervention using the Template for Intervention Description and Repli-
cation (TIDieR) checklist [26]. Briefly, exercise group participants received a physiotherapist-
led exercise education session, an exercise guidebook and weekly telephone-calls from the
research team. The multi-component exercise programme comprised a combination of
strength, aerobic and balance exercises [24]. There were six exercises within the programme,
with each having four different levels of difficulty. Participants categorised as frail were advised
to perform level one exercises initially, whereas pre-frail participants could start with level two
exercises. Exercise progression was discussed during weekly telephone calls with aim of main-
taining a rating of perceived exertion (RPE) score of 12–16 (i.e. moderate intensity) for exer-
cises 2–6 [27].
Primary outcome measures
Primary outcome measures included eligibility, recruitment, intervention adherence, outcome
measure completion and participant attrition rate. Reasons for ineligibility and non-consent
were recorded. In the intervention arm, reasons for non-adherence were documented. Rea-
sons for failure to complete outcome measures and for study withdrawal were also recorded.
Table 1. TIDieR checklist.
Item
Brief name The EX-FRAIL CKD Exercise Programme.
Rationale Exercise training is associated with improved health outcomes in adults with CKD.
Evidence also suggests that home-based exercise interventions may improve outcomes in
older adults.
Materials Exercise guidebook, exercise diary and wrist/ankle weights.
Procedures Exercise education session and weekly telephone-calls.
Provider Exercise education was delivered by a physiotherapist. Telephone calls were performed by a
physiotherapist or specialist trainee with relevant experience.
Modes of delivery Face-to-face exercise education session followed by weekly telephone calls.
Location Exercise education sessions were delivered in a private room at NIHR Lancashire Clinical
Research Facility. Exercises were completed in a participant’s own home.
Frequency and
duration
Participants received an education session that lasted approximately 60 minutes.
Participants aimed to perform 3 exercise sessions at home per week, each lasting
approximately 30–45 minutes.
Tailoring Initial exercise levels were determined by frailty status, unless the physiotherapist
determined otherwise due to safety concerns. If a participant could perform any of the
exercises comfortably after week 1, exercise progression was discussed with the participant.
Modifications An alternative exercise was provided if a participant was unable to perform an exercise as
originally intended. If a participant was unable to complete the proposed repetitions, they
were advised to perform a lower number initially.
Adherence and
fidelity
Exercises were delivered as described in the exercise guidebook. If modification was
needed, the participant was provided additional documentation. Adherence was assessed
during telephone calls and through review of exercise diaries. Outcomes of telephone calls
were discussed within the research team. See also ‘Intervention Adherence’ in ‘Results’
section.
CKD, chronic kidney disease. NIHR, National Institute of Health Research.
https://doi.org/10.1371/journal.pone.0251652.t001
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Progression criteria are recommended for pilot trials to assess whether there should be pro-
gression to a definitive RCT [28]. Trial progression criteria were determined a priori by the
research team: (1) eligibility: stop<5%, go >10%; (2) recruitment: stop <10%, go>30%; (3)
exercise adherence: stop: <30%, go>70%; (4) outcome measure completion: stop <70%, go
>80%; and (5) loss to follow-up: stop >50%, go<25%.
Secondary outcome measures
An overview of secondary outcome measures is provided below; a detailed description has
been published previously [24]. All measures were performed at baseline and at 12-week fol-
low-up visits.
1. Physical Function: Physical function was assessed by measuring walking speed and the
Short Physical Performance Battery (SPPB) [29].
2. Frailty: Frailty was assessed using the original FP [13]. Participants were categorised as frail
if 3 or more FP components were present and as pre-frail if 1 or 2 FP components were
present.
3. Activities of Daily Living: The Barthel Index questionnaire was used to evaluate indepen-
dence with 10 activities of daily [30].
4. Falls: The Falls Efficacy Scale-International (FES-I) questionnaire was used to assess fall
concern [31]. The number of falls within the preceding 6 months was also recorded.
5. Symptom-Burden: The Palliative Care Outcome Scale-Symptoms RENAL (POS-S
RENAL) questionnaire was used to assess symptom burden [32].
6. HRQOL: The Short Form-12v2 (SF-12) was used to assess HRQOL and was used to gener-
ate physical and mental health summary measures (PCS and MCS, respectively) [33].
Interviews
Semi-structured interviews were conducted, using a predetermined topic guide, with a purpo-
sively selected group of participants from both study arms, considering age, sex and frailty status.
Interviews explored the acceptability of the randomisation procedure, outcome measures and,
in the intervention arm, of the progressive home-based exercise programme. The Chief Investi-
gator (ACN), a Specialist Trainee in Renal Medicine, conducted all interviews. ACN received
training from an experienced qualitative researcher (KWF). During interviews ACN was cogni-
sant of the potential for personal bias, given his prior association with participants and the sub-
ject area. Interviews and transcripts were regularly discussed and reviewed with KWF for
potential bias concerns. Further detail on the interviews has been published previously [24].
Sample size
The target sample size was 40 participants, which allowed for a dropout rate of up to 50% and
would still provide sufficient data to assess study feasibility and inform a sample size calcula-
tion for a definitive RCT [34,35]. A sample of 12–14 participants was the goal for the qualita-
tive study and anticipated to achieve data saturation.
Randomisation and blinding
A central, concealed web-based randomisation process (www.sealedenvelope.com) was
performed in blocks of 4 with stratification limited to one factor, FP status. Blinding of
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participants was not possible due to the nature of the intervention. Blinding of outcome asses-
sors was not performed in this pilot RCT for pragmatic reasons.
Data analyses
Quantitative outcome measures are reported descriptively with 95% confidence intervals (CI).
Analysis of Covariance (ANCOVA) was performed on normally distributed data relating to
secondary outcome variables to descriptively present the mean difference (and associated stan-
dard deviation) between groups whilst adjusting for baseline measurements. Barthel Index
score data were not normally distributed and are therefore presented as median and interquar-
tile range (IQR). Data relating to frailty status, a categorical variable, are presented as frequen-
cies and percentages. SPSS Statistics (version 25.0.0.1, IBM Corp) and R (version 4.0.2, R
Foundation for Statistical Computing) statistical software were used to conduct statistical anal-
yses. The intervention effect size (Cohen’s d) was calculated and used to inform the sample
size calculations for a future trial. G�Power (version 3.1.9.4) was used to perform the sample
size calculations [36]. Qualitative data was analysed using thematic analysis; narrative seg-
ments were coded and then collated into potential themes, which were iteratively reviewed to
develop a ‘thematic map’ [37]. NVivo software (version 12.6.0, QSR International) was used to
support qualitative analysis. Qualitative and quantitative findings were linked [38] and pre-
sented in a ‘joint display’ [39].
Results
Participant recruitment
The trial opened in August 2018; data collection was completed in December 2019. Fig 1 dem-
onstrates the participant flow throughout the study. Six hundred and sixty-five patients had an
eligibility assessment with 217 (33%; 95% CI 29, 36) eligible for enrolment. Four hundred and
forty-eight (67%; 95% CI 64, 71) patients were considered ineligible. Reasons for ineligibility
are detailed in S1 Table. One hundred and fifty-three (23%; 95% CI 20, 26) patients declined
participation. Most patients did not offer a reason for declining participation (n = 79; 52%;
95% CI 43, 60). Reported reasons for declining participation are detailed in S2 Table. The
research team were unable to contact 28 (4%; 95% CI 3, 6) patients to complete the eligibility
assessment and were unable to accommodate a baseline study visit for 1 (0.46%; 95% CI 0.02,
2.94) eligible patient prior to recruitment closure. A total of 35 (16%; 95% CI 12, 22) partici-
pants were recruited to the study. Six (17%; 95% CI 7, 34) were categorised as robust using the
FP assessment and were withdrawn prior to randomisation. Fifteen participants were rando-
mised to the exercise group and 14 to the usual care group.
Participant demographics and clinical characteristics
Table 2 details participant demographics and clinical characteristics. Four (29%; 95% CI 10,
58) participants were categorised as frail in the usual care group compared to 5 (33%; 95% CI
13, 61) in the exercise group. The remaining participants were categorised as pre-frail.
Progression criteria results
A median of 28 (IQR 16) exercise sessions were completed during the 12-week intervention
period. Eleven (73%; 95% CI 45, 91) exercise group participants completed�2 exercise ses-
sions per week, with a mean of 36.5±8.5 minutes spent exercising each session. The mean RPE
score for exercises 2–6 was 12±2. The main reasons for missing exercise sessions were pain
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(n = 14; 56%; 95% CI 35, 75), participant wishes (n = 7; 28%; 95% CI 13, 50) and feeling unwell
(n = 4; 16%; 95% CI 5, 37).
Retained usual care and exercise group participants completed all outcome measures
(n = 21; 100%; 95% CI 81, 100). Eight (28%; 95% CI 13, 47) participants were withdrawn from
the study. Two (14%; 95% CI 3, 44) participants were withdrawn from the usual care group;
the research team learned issues following randomisation that meant participation in an exer-
cise programme was considered unsafe. Six (40%; 95% CI 17, 67) participants were withdrawn
from the exercise group: musculoskeletal pain (n = 3; all made a complete recovery), pre-
scribed specific exercise by a physiotherapist during the trial period (n = 1) and participant
wishes (n = 2).
Physical function and patient reported outcome measures
Table 3 presents between-group differences in physical function and patient reported out-
comes. The adjusted mean group difference in walking speed and SPPB between exercise and
usual care groups were: 0.01 metres/second (95% CI -0.07, 0.10) and 0.5 (95% CI -0.9, 1.8),
respectively. The adjusted mean group difference in FESI, POS-S RENAL, SF-12 PCS and SF-
12 MCS were: 3.4 (95% CI -3.5, 10.3), -1.4 (95% CI -6.6, 3.7), -3.9 (95% CI -9.3, 1.5) and 0.2
Fig 1. Study flow diagram.
https://doi.org/10.1371/journal.pone.0251652.g001
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Table 2. Participant demographics and clinical characteristics.
Usual Care (n = 14) Exercise (n = 15)
Age, years, mean ±SD 78.8 ±7.0 77.0 ±8.3
Female, n (%) 7 (50) 6 (40)
Ethnicity
• White British, n (%) 14 (100) 15 (100)
Primary Renal Disease, n (%)
• Renovascular/Ischaemic 7 (50) 5 (33)
• Diabetic 2 (14) 0 (0)
• Cardio-renal 0 (0) 2 (13)
• Glomerulonephritis 1 (7) 3 (20)
• Obstructive Uropathy 0 (0) 2 (13)
• Other 3 (21) 3 (20)
• Unknown 1 (7) 0 (0)
CCI, mean ±SD 3.4 ±0.9 4.2 ±1.3
Medications, median (IQR) 8.5 (6.3) 9.0 (5.0)
Smoking History, n (%)
• Non-smoker 4 (29) 5 (33)
• Ex-smoker 8 (57) 8 (53)
• Current smoker 2 (14) 2 (13)
Living Circumstances, n (%)
• Alone 8 (57) 8 (53)
• With Family 6 (43) 7 (47)
Received Carer Support, n (%) 0 (0) 2 (13)
CFS Score, n (%)
• 4: Vulnerable 8 (57) 10 (67)
• 5: Mildly frail 2 (14) 5 (33)
• 6: Moderately frail 4 (29) 0 (0)
Frailty Phenotype
• Pre-Frail 10 (71) 10 (67)
• Frail 4 (29) 5 (33)
Fall Previous 6 Months, n (%) 1 (7) 0 (0)
BMI, kg/m2, mean ±SD 29.4 ±5.7 29.4 ±6.9
Blood Pressure, mean ±SD
• Systolic, mmHg 142.6 ±11.5 139.5 ±18.5
• Diastolic, mmHg 70.1 ±10.6 70.4 ±9.4
Laboratory Variables, mean ±SD
• Creatinine, μmol/L 239.5 ±63.4 274.4 ±106.1
eGFR, ml/min/1.73m2 20.4 ±7.2 18.9 ±7.0
• Haemoglobin, g/L 117.6 ±15.6 117.1 ±6.7
• Albumin, g/L 42.9 ±3.9 40.5 ±2.5
CCI, Charlson Comorbidity Index, BMI, Body Mass Index; eGFR, estimated Glomerular Filtration Rate.
Data presented as number (%), mean ± SD or median (IQR).
https://doi.org/10.1371/journal.pone.0251652.t002
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(95% CI -6.2, 6.6), respectively. The median Barthel Index scores for the usual care group at
baseline and follow-up were 95 (IQR 5; 95% CI 95, 100) and 95 (IQR 9; 95% CI 90, 100),
respectively. The median Barthel Index scores for the exercise group at baseline and follow-up
were 100 (IQR 8; 95% CI 90, 100) and 100 (IQR 8; 95% CI 90, 100), respectively. Table 4 pres-
ents the frailty status change for usual care and exercise groups. The relative risk for improve-
ment in frailty status with exercise was 4.0 (95% CI 0.7, 25.6).
Adverse events
There were 32 adverse events in the exercise group and 22 in the usual care group. There were
12 adverse reactions (i.e. adverse events related to the intervention): musculoskeletal pain (9),
fall (1), nocturnal leg cramps (1) and postural dizziness (1). There were no adverse events
related to the trial outcome measures. Within the exercise group, there were 2 serious adverse
events (hospitalisations due to an infection) unrelated to the intervention.
Sample size estimation
The calculated mean change (and associated standard deviation) in outcome measures pre-
sented in Table 3 were used for sample size estimation. With an alpha of 0.05%, calculations
indicated that to achieve 80% power a minimum sample size of 1542, 268 and 200 participants
Table 3. Between-group differences in physical function and patient reported outcomes.
Usual Care Group (n = 12) Exercise Group (n = 9) Unadjusted between-group
differences Mean (95% CI)
Adjusted between-group
differences Mean (95% CI)Mean ±SD (95% CI) Mean ±SD (95% CI)
Outcome
Measure










































3.7 (-6.6, 14.1) 3.4 (-3.5, 10.3)






































2.0 (-6.5, 10.4) 0.2 (-6.2, 6.6)
m/s, metres/second; SPPB, Short Physical Performance Battery; FESI, Falls Efficacy Scale-International; POS-S RENAL, Palliative care Outcome Scale-Symptoms
RENAL;
SF-12 PCS, Short Form-12v2 Physical Component Summary; SF-12 MCS, Short Form-12v2 Mental Component Summary.
Data presented for participants that completed follow-up assessments (n = 21).
https://doi.org/10.1371/journal.pone.0251652.t003
Table 4. Frailty status change for usual care and exercise groups.
Frailty Status Change Usual Care Exercise
Frequency Percentage (95% CI) Frequency Percentage (95% CI)
Improved 1 8 (0.2, 38.5) 3 33 (7.5, 70.1)
Unchanged 9 75 (42.8, 94.5) 5 56 (21.2, 86.3)
Worse 2 17 (2.1, 48.4) 1 11 (0.3, 48.3)
https://doi.org/10.1371/journal.pone.0251652.t004
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would be needed to determine differences between usual care and exercise group participants’
walking speeds, SPPB scores and POS-S Renal scores, respectively, following the exercise
intervention.
Qualitative results
Fifteen participants agreed to take part in interviews. Seven participants had been randomised
to usual care and 8 participants to exercise. One exercise participant withdrew from the study
prior to completion of the exercise intervention but agreed to participate in the qualitative
study. Qualitative study participant demographics are presented in S3 Table. Identified themes
were related to the feasibility of the trial and the intervention itself. S4 Table presents these
themes alongside supportive quotes. A joint display of the quantitative and qualitative results
with regards to the study progression criteria is presented in Table 5.
Many participants’ decision to take part in the study was motivated by a sense of altruism,
whereas others were motivated by the potential for personal gain. Participants’ decision-mak-
ing was also influenced by family members and trusted healthcare professionals. Although
many were indifferent about the randomisation process, some had definite preferences and
were disappointed with the outcome of randomisation. Some participants acknowledged that
they felt frail and were not deterred by the word ‘frail’. One participant did not identify as
being frail by their understanding of the term. Overall, participants understood the rationale
for the outcome assessments and accepted their inclusion within the study visits. One partici-
pant reported frustration with the patient-reported outcome measures (PROMs), specifically
with regards to the number of questions asked and the time taken to complete the PROMs.
They did not highlight any one PROM being more problematic than another.
Some participants expressed fear, particularly fear of pain, at the thought of participating in
exercise or being more physically active. Several participants highlighted the importance of
positive staff attitude when delivering exercise education and supporting participant engage-
ment with exercise. Participants found the concept of RPE unfamiliar. Only one participant
remained dismissive of recording RPE scores. A variety of factors influenced participants’
motivation to exercise including: personal goals; self-determination and resilience; personal
responsibility to participate after study consent; a sense of achievement following exercise ses-
sion completion; telephone calls with the research team; exercise location; exercise enjoyment










35 16 (12, 22) Factors affecting decision to participate included altruism, potential for
personal gain and influence of family/health professionals.
Mixed feelings about randomisation process.
Some concerns about ability to participate in exercise due to own mobility





11 73 (45, 91) Exercise adherence influenced by staff attitude/support, participant personality
traits and personal goals, participant fear of pain/injury, exercise difficulty and















8 28 (13, 47) Participant decision to withdraw influenced by perceived exercise




PLOS ONE The EX-FRAIL CKD Trial
PLOS ONE | https://doi.org/10.1371/journal.pone.0251652 July 1, 2021 10 / 16
(or lack thereof); and perceived ineffectiveness of exercise. Participants reported liking exercis-
ing at home, citing convenience, flexibility and privacy as being positive aspects of the exercise
programme. Several participants described the benefits that they experienced, including:
improved fitness, balance and strength. Participants also described improvements in their
well-being, energy levels and confidence. Finally, involvement in the study promoted self-
reflection, in terms of personal levels of physical activity and functional ability, which moti-
vated participants to be more active.
Discussion
To our knowledge, this is the first trial involving a home-based exercise programme for pre-
frail and frail older adults with CKD. Progression criteria thresholds were exceeded for eligibil-
ity, adherence and outcome measure completion. However, recruitment and loss to follow-up
progression criteria thresholds were not achieved. The use of a mixed-methods approach pro-
vided a comprehensive evaluation of study procedures and the intervention, highlighting
potential areas requiring adaptation.
Although, the use of the word ‘frail’ did not deter participants from taking part in our
study, the term can be viewed negatively [40]. The inclusion of this in the study materials may
have deterred some patients from discussing study involvement. Rather than avoid this termi-
nology, study materials could provide a more detailed explanation of the language of frailty.
Participants described concerns about their ability to participate in exercise due to perceived
mobility issues or because of concerns about exercise eliciting or exacerbating pain. These
findings highlight the importance of early face-to-face discussions between potential partici-
pants and informed healthcare professionals to address these concerns. There were also mixed
feelings about the randomisation process with some participants having a preferred study arm.
Adoption of a delayed-start trial design would hopefully dispel these reservations, though
would necessitate a longer study period [41].
There is an anticipated attrition rate with any study, not least studies involving an older,
frail and multimorbid population [42]. Studies of home exercise interventions for older adults
living with frailty have reported retention rates ranging from 53–98% [22]. In our study, deci-
sion to withdraw appeared to be influenced by perceived ineffectiveness and a fear of worsen-
ing symptom experience with physical activity. These findings have been reported previously
in patients with CKD [43,44]. A previous study that evaluated 12 weeks of supervised exercise
demonstrated an improvement in symptom-burden for people with CKD [45]. There was an
increase in the frequency of ‘joint/bone pain’ with the intervention that included resistance
training; however, this was not statistically significant [45]. Importantly, the intervention
resulted in a reduction of ‘loss of muscular strength/power’ symptoms [45] and an objective
improvement in muscle mass and strength [46]. Further education about the potential benefits
of exercise on symptom experience should be provided to participants from the outset, whilst
acknowledging that it is not uncommon to experience transient discomfort when increasing
physical activity levels.
With a home-based exercise intervention, participants require the appropriate knowledge,
skills and confidence to actively engage with the intervention, otherwise known as patient acti-
vation [47]. Low patient activation levels are described in older patients living with frailty [48]
and older patients living with advanced CKD [49]. Additional efforts to improve patient acti-
vation, specifically tailored to the individual participant [50], may promote participant reten-
tion. Considering the theory of planned behaviour, positive enhancement of an individual’s
perceived behavioural control, i.e. the “perception of the ease or difficulty of performing the
behaviour of interest”, is beneficial [51]. Furthermore, self-determination theory suggests
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intrinsic motivation is an important factor for behaviour change; therefore encouraging partic-
ipant autonomy may improve participant retention [52].
Although confidence intervals were expectedly wide, exercise group participants had a 0.5
(95% CI -0.9, -1.8) score increase in SPPB- an acknowledged meaningful score change [50].
Notably, there was also an improvement in POS-S RENAL score (-1.4; 95% CI -6.6, 3.7),
though again confidence intervals were wide. Participants reported experiencing benefits
related to exercise, including improved fitness, balance, strength, well-being, energy levels and
confidence. Although this study was not powered to investigate the effectiveness of the home-
based exercise programme, these findings suggests that the intervention may offer benefits to
people living with frailty and CKD.
A sample size of 1542 participants would be needed for a definitive RCT that used walking
speed as the primary outcome measure. Even before accounting for participant attrition, this is
clearly an unrealistic target. A more realistic sample size of 268 and 200 participants would be
needed if using the SPPB or POS-S Renal, respectively. Physical function and symptom-bur-
den are clinical outcomes relevant and important for people living with CKD and people living
with frailty alike [14,15,53–55]. Therefore, we suggest that either may be used as the primary
outcome measure of interest in a RCT investigating the effectiveness of a home-based exercise
programme in this patient population.
Notwithstanding this pilot RCT’s strengths, there are acknowledged limitations. Recruited
participants were all White British and the feasibility of a RCT in other populations cannot be
presumed. For pragmatic reasons, patients that declined enrolment in the main study were not
offered the opportunity to participate in the qualitative study. Therefore, reasons for non-
enrolment can only be reported descriptively based upon patient comments. Most participants
enrolled in the study were categorised as pre-frail by the FP. It is possible that patients living
with frailty, particularly more severe frailty, have greater concerns about participating in exer-
cise, either due to lack of confidence or burden of frailty and co-morbidity. There is therefore
a risk that the suggested trial adaptations do not adequately address this potential recruitment
issue. Exercise adherence was measured using exercise diaries and weekly telephone calls,
which are subject to recall bias. However, this was considered the most realistic approach as
using an accelerometer would: (1) not distinguish between exercise and other activity; and (2)
introduce an additional parameter that may influence behaviour change, i.e. participants using
the accelerometer may be more motivated to exercise. Participants involved in the qualitative
study were interviewed by a researcher also involved in the delivery of the intervention. How-
ever, participants were informed that the purpose of the interview was to understand their
experience of the study to identify areas for improvement for a definitive RCT. Finally, blind-
ing of outcome assessors should be considered for a RCT investigating the effectiveness of the
intervention.
In summary, the EX-FRAIL CKD trial demonstrates that progression to a large-scale defini-
tive RCT is possible provided recruitment and retention challenges are addressed. Further-
more, it has determined the necessary sample size for a RCT using clinically relevant and
important primary outcome measures for the study population. Finally, it has provided pre-
liminary evidence that home-based exercise may be beneficial for people living with frailty and
CKD.
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